_db33a8.png)
Babraham Research Campus stands as a vibrant, sustainable ecosystem dedicated to fostering bioscience research and innovation, with a mission to drive new discoveries, therapeutics, jobs, and growth to bolster the UK economy. It aims to be a premier sustainable ecosystem and a global leader in discovery bioscience research and innovation. By integrating world-class bioscience research with business, the campus accelerates scientific discovery and supports the development and scaling of enterprises.
Scaleups at Babraham Research Campus benefit from a supportive infrastructure, with access to laboratories and office spaces on flexible short-term leases, allowing them to expand into larger facilities as they grow. The Accelerate@Babraham bioincubator programme, lauded as one of the top 25 in Europe by Labiotech, offers further support to early-stage life science scaleups. This five-month initiative provides bespoke scientific, business, and technical support, complimentary lab space, integration into the Cambridge Cluster network, introductions to investors, and £10,000 in non-dilutive funding. Entry into the programme is competitive, with an annual application and pitching process that selects up to five early-stage ventures for each cohort.
For scaleups seeking investment, the annual Babraham Investor Conference, most recently held in September 2023, creates a collaborative and informative environment. This event connects hundreds of investors, companies, and industry leaders, facilitating access to venture capital investment.
In October 2023, the Campus, in partnership with BioMed Realty, announced the upcoming opening of a new 34,000 square foot facility, responding to the increasing demand for lab space in Cambridge. This purpose-built facility, expected to open in early 2024, will house expanding scale-up labs, including businesses like Xap Therapeutics and Mosaic Therapeutics.
A 2020 assessment of the Campus' economic impact revealed significant benefits for resident companies. On average, firms accelerated their fundraising by three months and increased the amount raised by 10%. Additionally, employee numbers in these firms were approximately 20% higher than they might have been elsewhere, attributed to the Campus' location. The total market value of the 14 largest companies on-site was estimated at £5 billion.
